A discussion with Michael Reardon, M.D. about the state of transcatheter aortic valve replacement (TAVR) as of late 2016 ...
November 9, 2016 โ A dedicated stent study conducted exclusively in women and minority patients evaluated clinical ...
Patients who undergo minimally invasive heart valve replacement, known as transcatheter aortic valve replacement (TAVR), sometimes develop heart rhythm problems that necessitate placement of a permanent pacemaker. However, when a pacemaker is needed soon after TAVR, patients often have worse outcomes than those who did not need a pacemaker, according to a study published recently in JACC: Cardiovascular Interventions. The study shows that the risks are both short- and long-term and include lengthier hospital and intensive care unit stays as well as a greater risk of death.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Juan Granada, M.D., executive director and chief scientific officer of the Cardiovascular Research Foundation's Skirball ...
Brijeshwar Maini, M.D., and Brian Bethea, M.D., from Tenet Floridaโs structural heart program, explain the importance of ...
November 9, 2016 โ Results from a randomized, multicenter trial failed to show non-inferiority of hybrid, ultra-thin ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Krishna Rocha-Singh, M.D., Prairie Vascular Institute, Springfield, Ill., explains advancements in device therapy for ...
David Kandzari, M.D., director of interventional cardiology and chief scientific officer, Piedmont Heart Institute ...
Studies have shown transcatheter aortic valve replacement (TAVR) has an increased risk of stroke and cerebral damage due ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Edwards Lifesciences Corp. recently announced new data demonstrating dramatic and sustained improvements in quality of life for severe aortic stenosis (AS) patients at intermediate surgical risk treated with Edwards transcatheter heart valves. Study results were presented at the 28th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, in Washington, D.C.
November 7, 2016 โ Results from the U.S. real-world, post-FDA approval experience of the Watchman device found high ...
Keystone Heart Ltd. announced that data presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2016 scientific symposium demonstrate an increase in brain lesions for patients following transcatheter aortic valve replacement (TAVR) procedures, which were significantly associated with delirium.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 7, 2016 โ Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (OCT) ...
November 7, 2016 โ A multicenter randomized trial evaluating the role of embolic protection using the Sentinel device ...
November 7, 2016 โ The two-year results from LEADERS FREE, the first randomized clinical trial dedicated to high ...